mAbTree Biologics

mAbTree Biologics is an Indian-based startup that focuses on developing innovative human antibodies to address high unmet medical needs. Founded in 2019, the company operates in the biopharma and biotechnology sectors, aiming to revolutionize the treatment of various diseases. With a vision centered on the innovation of proprietary human monoclonal antibodies, mAbTree Biologics is dedicated to making a significant impact on the field of healthcare.

As of now, there is no record of the company's last investment or the involved investors. Despite this, mAbTree Biologics presents a compelling prospect for potential venture capital partners seeking to contribute to advancements in the biopharmaceutical and biotechnological arenas. The strategic focus on developing human antibodies sets the company apart and offers an exciting opportunity for investment in a forward-thinking, cutting-edge biotech startup.